[HTML] nih.gov

[HTML][HTML] Cost effectiveness of a potential vaccine for human papillomavirus

GD Sanders, AV Taira - Emerging infectious diseases, 2003 - ncbi.nlm.nih.gov
Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor
for cervical cancer. Given the substantial disease and death associated with HPV and …
被引用次数：435 相关文章 所有 11 个版本
[HTML] nih.gov

[HTML][HTML] Cost-effectiveness of human papillomavirus vaccination in the United States

HW Chesson, DU Ekwueme, M Saraiya… - Emerging infectious …, 2008 - ncbi.nlm.nih.gov
We describe a simplified model, based on the current economic and health effects of human
papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old …
被引用次数：185 相关文章 所有 15 个版本
[HTML] nih.gov

[HTML][HTML] Evaluating human papillomavirus vaccination programs

AV Taira, CP Neukermans… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical
cancer. Potential vaccines against high-risk HPV types are in clinical trials. We evaluated …
被引用次数：535 相关文章 所有 12 个版本
[PDF] oup.com

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses

TA Westra, MH Rozenbaum, RM Rogoza… - Journal of Infectious …, 2011 - academic.oup.com
Introduction. Cervical cancer is caused by infection with human papillomavirus (HPV).
Several countries have implemented vaccination programs against HPV for teenage girls …
被引用次数：89 相关文章 所有 16 个版本
[HTML] nih.gov

[HTML][HTML] Model for assessing human papillomavirus vaccination strategies

EH Elbasha, EJ Dasbach… - Emerging infectious …, 2007 - ncbi.nlm.nih.gov
We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent …
被引用次数：589 相关文章 所有 12 个版本

The cost-effectiveness of male HPV vaccination in the United States

HW Chesson, DU Ekwueme, M Saraiya, EF Dunne… - Vaccine, 2011 - Elsevier
INTRODUCTION: The objective of this study was to estimate the cost-effectiveness of adding
human papillomavirus (HPV) vaccination of 12-year-old males to a female-only vaccination …
被引用次数：267 相关文章 所有 11 个版本
[PDF] researchgate.net

Mandatory HPV vaccination: public health vs private wealth

LO Gostin, CD DeAngelis - Jama, 2007 - jamanetwork.com
BY ANY MEASURE, GENITAL HUMAN PAPILLOMAVIRUS (HPV) infection and HPV-
associated cervical can-cer are significant national and global public health concerns. An …
被引用次数：121 相关文章 所有 7 个版本
[HTML] nih.gov

Population impact of HPV vaccines: summary of early evidence

S Hariri, LE Markowitz, EF Dunne, ER Unger - Journal of Adolescent Health, 2013 - Elsevier
Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …
被引用次数：90 相关文章 所有 10 个版本
[PDF] psu.edu

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada

M Brisson, N Van de Velde, P De Wals, MC Boily - Vaccine, 2007 - Elsevier
AIM: Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be
effective against infection and disease. We examined whether HPV vaccination has the …
被引用次数：220 相关文章 所有 10 个版本
[PDF] cmaj.ca

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection

M Brisson, N Van de Velde, P De Wals, MC Boily - Cmaj, 2007 - Can Med Assoc
Background: A vaccine against human papillomavirus (HPV) types 6, 11, 16 and 18 is now
licensed for use in Canada and many other countries. We sought to estimate the number …
被引用次数：90 相关文章 所有 12 个版本